Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002682 · ClinicalTrials.gov registry record · Phase 2
Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach
A Phase 2 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 5
- Enrollment target
NCT00002682: Completed Phase 2 study, sponsored by M.D. Anderson Cancer Center.
NCT00002682 is a Phase 2 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 5 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002682, a Phase 2 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 5 participants
- Enrollment target
Study Summary
RATIONALE: Antibiotic therapy and antacids are used to treat Helicobacter pylori infection of the stomach. These treatments may also have an effect on gastric MALT lymphoma of the stomach. PURPOSE: Phase II trial to study the effectiveness of antibiotic therapy with amoxicillin, clarithromycin, tetracycline, and metronidazole plus antacids in patients with MALT lymphoma of the stomach.
Interventions
- DRUG Amoxicillin
- DRUG Omeprazole
- DRUG Clarithromycin
- DRUG Bismuth Subsalicylate
- DRUG Metronidazole Hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 1995-08-10 |
| Est. Completion | 2001-10-08 |
| Phase | Phase 2 |
What the finished NCT00002682 record still lists
NCT00002682 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 5 interventions - of which Amoxicillin is the first listed.
NCT00002682 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002682 about?
NCT00002682 is a clinical study titled "Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach". RATIONALE: Antibiotic therapy and antacids are used to treat Helicobacter pylori infection of the stomach. These treatments may also have an effect on gastric MALT lymphoma of the stomach. PURPOSE: Phase II trial to study the effectiveness of antibiotic therapy with amoxicillin, clarithromycin, tet...
What is the current status of trial NCT00002682?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 5 participants. The study started on 1995-08-10. Estimated completion is 2001-10-08.
What interventions are being tested in trial NCT00002682?
The interventions under investigation include: Amoxicillin (DRUG), Omeprazole (DRUG), Clarithromycin (DRUG), Bismuth Subsalicylate (DRUG), Metronidazole Hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00002682?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00002682's enrollment target sits among peer trials
5 2000th of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI